M.Sc

Dr. B.R. Ambedkar Center for Biomedical Research (ACBR) was established in March 1991 as part of Centenary celebrations of Baba Saheb Dr. B.R. Ambedkar and its foundation stone was laid by the Hon'ble Prime Minister of India Sh. Chander Shekhar Ji on 31 st March 1991.The mandate of the Centre is postgraduate education and research in Biomedical Sciences.

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools.

The CSIR, established in 1942 with Corporate Office at New Delhi, and a network of 38 national laboratories spread over the country is a premier R & D Organisation in India providing S & T inputs to a diverse spectrum of economic, industrial and societal sectors. The R & D activities covers fields from aerospace engineering to ocean sciences, molecular biology to metallurgy, chemicals to mining, food to petroleum & leather to environment.

In 1994, when Smithkline Beecham tasked Medreich plc to source quality generic drugs, for its Africa operations, it came upon a little company that had world class quality parameters. This company was guided by the Beecham technical and regulatory protocols that it used in its own facility in UK. The little company, Medreich, has come a long way since then.

The Tata Memorial Hospital was initially commissioned by the Sir Dorabji Tata Trust on 28 February 1941 as a center with enduring value and a mission for concern for the Indian people.

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.